-
401
A Bayesian Markov Framework for Modeling Breast Cancer Progression
Published 2024-12-01“…This study develops a three-state Markov framework to estimate the transition rates between normal, preclinical screen-detectable phase (PCDP), and clinical breast cancer using simulated data. …”
Get full text
Article -
402
Thrombospondin-1: Multiple Paths to Inflammation
Published 2011-01-01“…The effects of TSP-1 have been studied in many preclinical tumor models, and mimetic peptides are being tested in cancer clinical trials. …”
Get full text
Article -
403
When molecular biology transforms clinical oncology: the EGFR journey in colorectal cancer
Published 2025-02-01“…The discovery of growth factors and their involvement in cancer represents the foundation of precision oncology. The preclinical and clinical development of agents targeting epidermal growth factor receptor (EGFR) in colorectal cancer (CRC) were accompanied by big hype and hopes, though the clinical testing of such agents clashed with intrinsic and acquired resistance, greatly limiting their therapeutic value. …”
Get full text
Article -
404
Statins in Asthma: Potential Beneficial Effects and Limitations
Published 2015-01-01“…However, the initial excellent results from the preclinical and animal studies have not borne the results in clinical trials that the scientific world was hoping for. …”
Get full text
Article -
405
Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma
Published 2025-03-01“…Purpose: Multiple myeloma (MM) tends to develop resistance to systemic therapy through multiple mechanisms that might as well induce radioresistance, as suggested by preclinical studies. The aim of the present analysis was to elucidate whether the number of systemic treatment lines received prior to radiation therapy (RT) might confer radioresistance and influence local response. …”
Get full text
Article -
406
-
407
Advanced 3D bioprinted liver models with human-induced hepatocytes for personalized toxicity screening
Published 2025-01-01“…The development of advanced in vitro models for assessing liver toxicity and drug responses is crucial for personalized medicine and preclinical drug development. 3D bioprinting technology provides opportunities to create human liver models that are suitable for conducting high-throughput screening for liver toxicity. …”
Get full text
Article -
408
CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibody
Published 2024-12-01“…However, 23ME–00610 does not bind CD200R1 of preclinical species such as cynomolgus monkey MfCD200R1. …”
Get full text
Article -
409
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
Published 2021-04-01“…Similarly, preclinical studies should be designed as much as possible to model the intended clinical setting. …”
Get full text
Article -
410
Laser Applications in Metal Orthodontic Bracket Debonding: A Systematic Review
Published 2025-01-01Get full text
Article -
411
Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins
Published 2012-01-01“…Clinical evidence indicates that heparin, commonly used for treatment of thromboembolic events in cancer patients, is beneficial for their survival. Preclinical studies confirm that heparin possesses antimetastatic activities that lead to attenuation of metastasis in various animal models. …”
Get full text
Article -
412
Bidirectional causality of physical exercise in retinal neuroprotection
Published 2025-12-01“…Finally, we discuss future directions for preclinical and clinical research in exercise and eye health.…”
Get full text
Article -
413
Antiviral Activity of Resveratrol against Human and Animal Viruses
Published 2015-01-01Get full text
Article -
414
Bacteria in Cancer Therapy: Renaissance of an Old Concept
Published 2016-01-01“…This review summarizes and compares the results of the past 150 years in bacteria mediated tumor therapy from preclinical to clinical studies. Lessons we have learned from the past provide a solid foundation on which to base future efforts. …”
Get full text
Article -
415
Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias
Published 2024-12-01“…In this review, we discuss the available preclinical and clinical evidence for PFA for atrial fibrillation, developments for ventricular arrhythmia (VA) ablation, and future perspectives.…”
Get full text
Article -
416
Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer’s Disease
Published 2018-01-01“…The results from recent preclinical studies regarding stem cell-based therapies are promising. …”
Get full text
Article -
417
Toxicological Review of Anticancer Plants Used in Traditional Medicine in Morocco
Published 2023-05-01“…Further research, including preclinical and clinical trials, should be conducted to investigate the potential therapeutic benefits of these plants. …”
Get full text
Article -
418
Advances in the Use of Stem Cells in Veterinary Medicine: From Basic Research to Clinical Practice
Published 2016-01-01“…Knowledge about how adult stem cells modulate the molecular signals to activate cell homing has also been increasingly determined, evidencing the mechanisms which enable cells to repair and regenerate injured tissues. Preclinical studies were designed for many animal models and they have contributed to the translation to the human clinic. …”
Get full text
Article -
419
Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease
Published 2018-01-01“…Ruxolitinib is an oral selective Janus-associated kinase 1 (JAK1) and JAK2 inhibitor that was initially approved by the FDA in 2014 for treatment of myelofibrosis. In preclinical and retrospective clinical studies, use of ruxolitinib was shown to reduce graft-versus-host-disease (GVHD) in allograft recipients with moderate/severe corticosteroid-dependent or refractory chronic GVHD. …”
Get full text
Article -
420
CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
Published 2025-01-01“…This review delves into the intricate role of CCL24 in fibrotic diseases, highlighting its impact on fibrotic, immune, and vascular pathways. We focus on the preclinical and clinical evidence supporting the therapeutic potential of blocking CCL24 in diseases that involve excessive inflammation and fibrosis.…”
Get full text
Article